ACOR - Acorda Therapeutics Inc Stock Price, Fair Value and News
$0.26-0.02 (-7.14%)
Market Closed as of 13 Jun 2024, 04:00 pm ET
ACOR Stock Valuation Analysis
Valuation
Login to View
Max Portfolio %
Login to View
ACOR Price Action
ACOR RSI Chart
ACOR Stock Valuation Analysis
Valuation
Login to View
Max Portfolio %
Login to View
ACOR Valuation
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
ACOR Fundamentals
ACOR Revenue
ACOR Earnings
ACOR Profitability
ACOR Investor Care
Revenue & Growth
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024 | 115.7M | - | - | - |
| 2023 | 118.3M | 116.9M | 111.1M | 117.6M |
| 2022 | 122.7M | 122.0M | 124.1M | 118.6M |
| 2021 | 153.7M | 151.9M | 130.3M | 129.1M |
| 2020 | 176.4M | 159.9M | 165.3M | 153.0M |
| 2019 | 409.4M | 306.2M | 211.1M | 192.4M |
| 2018 | 575.1M | 588.9M | 590.7M | 471.4M |
| 2017 | 523.1M | 535.1M | 540.5M | 588.3M |
| 2016 | 508.7M | 522.5M | 509.9M | 519.6M |
| 2015 | 420.8M | 437.4M | 479.6M | 492.7M |
| 2014 | 345.1M | 355.2M | 376.2M | 401.5M |
| 2013 | 306.4M | 317.8M | 325.3M | 336.4M |
| 2012 | 302.2M | 312.6M | 297.0M | 305.8M |
| 2011 | 234.5M | 257.0M | 286.4M | 292.2M |
| 2010 | 60.0M | 90.2M | 138.6M | 191.0M |
| 2009 | - | 50.1M | 52.4M | 54.7M |
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
| CEO | Dr. Ron Cohen M.D. |
|---|---|
| WEBSITE | acorda.com |
| SECTOR | Healthcare |
| INDUSTRY | Drug Manufacturers Specialty & Generic |
| EMPLOYEES | 111 |